Message #92 From:
gapper2 Date: April 25, 2008 08:16:49 AM
U.S. Precious Metals Appoints New CFO and Director
Press Release
Source: U.S. Precious Metals, Inc.
U.S. Precious Metals Appoints New CFO and Director Friday April 25, 8:00 am ET
CELEBRATION, Fla.--(BUSINESS WIRE)--U.S. Precious Metals, Inc. (USPR.OB OTCBB) today announced the appointment of Jesus M. Oliveras as Chief Financial Officer and Dr. Daniel Conte as Director. Speaking on behalf of the Board of U.S. Precious Metals, CEO Michael Jack Kugler stated, “Mr. Oliveras will oversee all finance and accounting functions, development of master budget, financial plan, quarterly reports and SEC reporting according to US GAAP accounting standards.”
ADVERTISEMENT
Mr. Oliveras presently is the Controller for International Power Group since 2007. He has been associated in the past with companies such as Ernst & Young, Pueblo International and Citibank. Prior to joining International power, he was the Director of Operations for the Ana G. Mendez University System where he is also adjunct professor in the area of finance and accounting. Mr. Oliveras has also been associated with companies such as Orange County Utilities, Centex Mortgage Company, and Goldstar Products, Inc., where he managed accounting and finance functions. Mr. Oliveras counts with ample experience in the accounting and finance fields, with publicly registered companies with global operations.
Mr. Oliveras attended the Wayne Huizenga School of Business and Entrepreneurship and Nova Southeastern University where he received his Masters in International Business Administration. Mr. Oliveras also attended the Inter American University where he received his Bachelor of Business Administration, Accounting & Finance.
Dr. Conte is Associate Attending Physician at the Hackensack University Medical Center, Hackensack, NJ, and also Associate Attending Physician at St. Mary’s Hospital, Passaic, NJ. From 1965 to 2008, Dr. Conte has been Chief Medical Officer for the Garfield Board of Education. Also, Dr. Conte was Chief Medical Examiner for John Hancock and Prudential Insurance from 1982 to 2003. Dr. Conte was member of the Board of Directors of the Towne Center Bank, Lodi, NJ from 2001 to 2003.
Dr. Conte's professional affiliations are: American Osteopathic Association, Bergen Passaic Medical Osteopathic Physicians and Surgeons, American College of Family Practice and New Jersey Association of Osteopathic Physicians and Surgeons.
Dr. Conte attended Villanova University (1953-1957) where he received his Bachelor of Science degree. Dr. Conte also attended Kirksville College of Medicine and Surgery (1959-1963). Dr. Conte served his Internship at the Doctor’s Hospital, Columbus, Ohio.
US Precious Metals, Inc. is a gold exploration company operating in Mexico through its wholly owned Mexican subsidiary, U.S. Precious Metals de Mexico. US Precious Metal’s common stock is quoted on the OTC Bulletin Board under the symbol "USPR."
Statements contained herein that are not based upon current or historical fact are forward-looking in nature. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. When used herein, the words "anticipate," "believe," "estimate," "plan," "intend" and "expect" and similar expressions, as they relate to U.S. Precious Metals, Inc., or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, such factors, including risk factors, discussed in the Company's Registration Statement on Form SB-2, as amended, and its Annual Report on Form 10-KSB, as amended, for the year ended May 31, 2007. Except as required by the Federal Securities law, the Company does not undertake any obligation to release publicly any revisions to any forward-looking statements to reflect.
